Full-Time

Sr Quality Specialist

Clinical Quality

Confirmed live in the last 24 hours

Takeda

Takeda

10,001+ employees

Global biopharmaceutical firm focused on R&D

No salary listed

Senior, Expert

Mumbai, Maharashtra, India

Domestic travels up to 30%

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Risk Management
Google Cloud Platform
Requirements
  • Life Sciences Graduate/Postgraduate with 7-10 years of years’ experience in clinical trial industry as Clinical Quality Auditor
  • Ability to work independently and identify compliance risks and escalate when necessary
  • Strong sense of urgency
  • Demonstrated interpersonal skills including strong negotiation skills
  • Excellent teamwork and coordination skills
  • Excellent verbal and writing skills and fluent in English and as applicable, local language is desired
Responsibilities
  • Drives the development and implementation of CQA procedures and local QMS (including GCP compliant process development) for managing local Clinical trial quality assurance in accordance with internal procedures.
  • Responsible as cross functional reviewer (where applicable) and quality authorizer as per internal procedures.
  • Establishing and maintaining local risk register. Engage the key LOC stakeholders to proactively identify GxP (primary focus GCP) quality risk areas, and establish appropriate risk mitigations and risk monitoring program at the LOC.
  • Lead supplier and individual clinical study audit(s) (internal and external including clinical site(s)) in accordance with internal procedures.
  • Provide independent quality and compliance oversight for GCP suppliers, including but not limited to coordinating the development and execution of Quality Agreements, attending Governance meetings etc.
  • Initiate Quality Incident Notification to Management / escalation report for notifiable events in accordance with Takeda Global Procedure.
  • Maintenance of LOC QMS system and ensuring its KPI’s are met. This includes handling of applicable QMS elements (including but not limited to) Change control, deviations, CAPA, complaints, Risk mitigation, gap assessments etc for GxP activities.
  • Responsible to ensure local Quality Council is conducted on a regular basis. Generate metrics and develop reports on GCP supplier quality performance.
  • Guiding Clinical Operations for adequate root cause identification, conducting gap analysis and implementation of corrective action plan (CAPA).
  • Provide GCP guidance to day-to-day questions arising from Clinical trials deliverables, as well as participate in review and approval of critical Clinical Study documents (e.g., Protocols), as appropriate.
  • Providing support during self-inspection, Takeda internal audits, supplier audit, any Regulatory inspection for LOC.
  • Manage relationship, relevant communication and inspection with local regulatory authority on GCP. Ensure regulatory commitments are duly completed on time.
  • Performing risk assessment of local GPvP vendors and schedule the audit accordingly.
  • Execution of Local GPvP vendor audit plan. Maintaining oversight if audit conduct shall be outsourced to consultant auditor.
  • Maintain training management for local Quality procedures in Takeda LMS and assignment of it to identified target GxP audience (under the role of system training administrator).
Desired Qualifications
  • Critical Thinking
  • Investigation and problem solving
  • Strong communication and stakeholder management skills
  • Ability to influence and work effectively with local cross-functional team
  • Agility and ability to manage complexity & balance priorities
  • Risk identification, evaluation, and management.

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, aiming for up to 15 product launches by FY2024. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's focus on personalized medicine can increase treatment efficacy and patient satisfaction.
  • Expansion in Southeast Asia offers opportunities for increased market presence and revenue growth.
  • Collaborations with tech companies can accelerate R&D processes and reduce costs.

What critics are saying

  • Data breach could lead to financial and reputational damage for Takeda.
  • Antitrust litigation with Meijer may result in financial penalties or business practice changes.
  • High financial commitments in partnerships could strain resources if outcomes are not achieved.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and R&D efforts.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 product launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.